ALAB
Astera Labs, Inc.
Stock
$356.42+0.45 (+0.13%)Close Oct 1, 2026
Income statement
| Line | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.2B | $853M | $396M | $116M | $80M |
| Cost of revenue | $299M | $207M | $94M | $36M | $21M |
| Gross profit | $903M | $645M | $303M | $80M | $59M |
| R&D | $434M | $304M | $201M | $73M | $74M |
| SG&A | $195M | $168M | $218M | $36M | $45M |
| Operating income | $273M | $173M | −$116M | −$29M | −$60M |
| Non-operating income | $49M | $45M | $34M | $6.5M | $2.6M |
| Pretax income | $322M | $218M | −$82M | −$23M | −$58M |
| Taxes | −$47M | −$981K | $1.6M | $3.3M | $764K |
| Net income | $369M | $219M | −$83M | −$26M | −$58M |
| Diluted EPS | $2.02 | $1.22 | −$0.64 | −$0.71 | −$1.71 |
| Diluted shares | — | 179.6M | 131.3M | 37.1M | 34.2M |
| Revenue growth | — | +115.1% | +242.2% | +45.0% | — |
| Gross margin | 75.1% | 75.7% | 76.4% | 68.9% | 73.5% |
| Operating margin | 22.8% | 20.3% | −29.3% | −25.5% | −75.4% |
| Net margin | 30.7% | 25.7% | −21.1% | −22.7% | −73.0% |
Cost of revenue, other operating expenses, non-operating income and taxes are the differences between the lines reported around them.